Group I metabotropic glutamate antagonist reduces acute neuronal degeneration and behavioral deficits after traumatic brain injury in rats

Experimental Neurology
B G LyethRobert F Berman

Abstract

Recent studies indicate that acute activation of Group I mGluRs following traumatic brain injury (TBI) contributes to the ensuing pathophysiology. The present study examined the effects of post-TBI administration of the selective mGluR1 antagonist (RS)-1-aminoindan-1,5-dicarboxylic acid (AIDA) on acute neuronal degeneration in the hippocampus and long-term sensorimotor and learning/memory outcome. In Experiment 1, 26 rats received 0.4, 2.0, or 10.0 nmol AIDA or artificial CSF vehicle infusion into the hippocampus starting 5 min postinjury. At 24 h after TBI characteristic pyramidal cell degeneration was observed in Fluoro-Jade-stained coronal sections of the CA2/3 sectors of the dorsal hippocampus. The mean (+/-SEM) number of Fluoro-Jade-positive neurons in the 10 nmol AIDA group (184 +/- 32) was significantly less (P < 0.05) than the vehicle group (310 +/- 47). In Experiment 2, 20 rats were trained on sensorimotor and memory tasks prior to parasagittal fluid percussion TBI. Rats were administered 10 nmol AIDA or vehicle as in Experiment 1. Rats were assessed on beam walking and radial arm maze (RAM) performance weekly for 6 weeks after TBI. Acquisition of a Morris water maze (MWM) task was assessed on days 11-15 after TBI. The...Continue Reading

References

Jan 13, 1978·Brain Research·D S OltonF H Gage
May 1, 1978·Physiology & Behavior·D S Olton, M A Werz
Nov 1, 1992·Journal of Neurobiology·D W Choi
Jul 1, 1987·Journal of Neurosurgery·C E DixonR L Hayes
May 1, 1984·Journal of Neuroscience Methods·R Morris
Jun 24, 1982·Nature·R G MorrisJ O'Keefe
Oct 8, 1982·Science·R P Kesner, J M Novak
Jan 1, 1995·Neuropharmacology·J P Pin, R Duvoisin
Jan 1, 1993·Trends in Pharmacological Sciences·D D Schoepp, P J Conn
Dec 31, 1997·Journal of Neurotrauma·D H SmithT K McIntosh
Feb 25, 1998·Journal of Neurotrauma·A I FadenA G Mukhin
Feb 11, 2000·Toxicologic Pathology·L C Schmued, K J Hopkins

❮ Previous
Next ❯

Citations

Dec 27, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Kimberly R ByrnesAlan I Faden
Aug 21, 2010·Nature Protocols·Shruti V KabadiAlan I Faden
Jan 25, 2005·Journal of Neurotrauma·Hilaire J ThompsonTracy K McIntosh
Jun 16, 2006·Journal of Neurotrauma·Pimonporn ChaovipochCandace L Floyd
Jul 6, 2013·Regenerative Medicine·Eric M GoldBrian J Cummings
May 3, 2011·Annual Review of Biomedical Engineering·Barclay MorrisonMartin L Yarmush
Sep 6, 2011·Journal of Neuroimmunology·D L GruolK Vo
Sep 9, 2006·CNS Drug Reviews·Paul M Lea, Alan I Faden
Sep 3, 2004·Neuroscience and Biobehavioral Reviews·Scott T FujimotoTracy K McIntosh
May 30, 2012·Neuropharmacology·C VolpiF Fallarino
Apr 9, 2005·Experimental Neurology·Kevin J AndersonStephen W Scheff
Jan 5, 2002·Mental Retardation and Developmental Disabilities Research Reviews·P M Lea, A I Faden
Nov 19, 2004·Journal of Neurophysiology·Kenira J ThompsonJoe L Martinez
Mar 11, 2003·Experimental Biology and Medicine·John B RedellPramod K Dash
Jun 10, 2019·Restorative Neurology and Neuroscience·Eric E AbrahamsonMilos D Ikonomovic
May 31, 2021·Seizure : the Journal of the British Epilepsy Association·Cesar E Santana-GomezBrian K Rundle
Sep 12, 2003·Trends in Pharmacological Sciences·Domenico E Pellegrini-Giampietro
Jun 8, 2021·Behavioural Brain Research·Nicholas S RaceRiyi Shi
Aug 27, 2021·Neuroscience and Biobehavioral Reviews·Matthieu FaillotSuhan Senova

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.